BioPharma Resources

Drug Trial Radar · NCT04215809

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

APG-2575CU101, A Phase Ib Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Last checked: Nov 19, 2026Latest source record: Apr 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

144

Planned (sponsor's estimate)

Start

Mar 2, 2020

Primary completion

Oct 31, 2025

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Ascentage Pharma Group Inc.Industry
Sponsor type
Industry
First posted
Jan 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess the safety and tolerability, identify dose-limiting toxicities (DLT) and determine the maximum tolerated dose (MTD) / recommended phase 2 dose (RP2D) of lisaftoclax.

Conditions

  • CLL/SLL

Interventions

  • LisaftoclaxDrug

    Lisaftoclax investigation drug in ramp up dosing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Toxicity Endpoint: dose limiting toxicity (DLT)Time frame: 42 days
  2. Maximally tolerated dose (MTD)Time frame: 42 days

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California · Recruiting

  • Mayo Clinic

    Jacksonville, Florida · Recruiting

  • Dana Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Novant Health

    Charlotte, North Carolina · Recruiting

  • Gabrail Cancer Center

    Canton, Ohio · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Swedish Health

    Seattle, Washington · Recruiting

  • Princess Alexandria Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Frankston Private Hospital

    Melbourne, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.